Lv1
30 积分 2024-03-28 加入
Responder End Points For Clinical Trials
4小时前
求助中
Can Open-Source AI Models Diagnose Complex Cases as Well as GPT-4?
9天前
已完结
Interstitial lung abnormalities: challenges and opportunity
30天前
已关闭
No plan B, no planet B: confronting the rising global burden of chronic respiratory diseases
30天前
已关闭
Wearable Devices Identify Altered Sleep Characteristics and Sleep Trajectories in Active Inflammatory Bowel Disease
1个月前
已关闭
Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalised patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomised controlled trial
2个月前
已关闭
Original article: Efficacy and safety of single-dose suraxavir marboxil tablet in the treatment of acute uncomplicated influenza in adults: a multi-center, randomized, double-blind, placebo-controlled phase 2 clinical trial
4个月前
已完结
Sex differences in COPD in relation to smoking exposure: a population-based cohort study
4个月前
已完结
Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial
4个月前
已完结
Got flu? Promising drug shortens symptoms
6个月前
已完结
皖公网安备34019202002308
